| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
292 |
287 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
40 |
39 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
17 |
17 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
70 |
70 |
$2K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
134 |
134 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$765.24 |
| 99173 |
|
39 |
39 |
$648.12 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
47 |
47 |
$505.30 |
| 96127 |
|
111 |
110 |
$472.86 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24 |
12 |
$233.88 |